Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Female 18-65 years of age (inclusive)~2. Diagnosed with IBS based on the following criteria (Rome III criteria):~   * Symptom onset at least 6 months prior to diagnosis, and~  * Recurrent abdominal pain or discomfort at least 3 days per month for the past 3 months, and~  * Abdominal discomfort or pain associated with two or more of the following at least 25% of the time:~  * improvement with defecation~  * onset associated with a change in frequency of stool/defecation~  * onset associated with a change in form (appearance) of stool~3. Diagnosed with IBS-D, defined as loose/watery stools ≥ 25% and hard/lumpy stools ≤ 25% of defecations~Exclusion Criteria:~* Any structural abnormality of the gastrointestinal (GI) tract (other than esophagitis or gastritis)~* History of Chron's disease, ulcerative colitis, diabetes mellitus, lactose malabsorption, malabsorption syndromes, celiac sprue, or any upper GI symptoms that may impact the assessment of IBS symptoms

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Experimental Arm 1 (Type: EXPERIMENTAL): ONO-2952 Active tablets, every day for 2 weeks
- Placebo Arm (Type: PLACEBO_COMPARATOR): ONO-2952 Matching Placebo every day for 2 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).